Stereotactic radiotherapy for soft tissue and bone sarcomas: real-world evidence
Introduction: Selected patients with locally advanced or metastatic soft tissue and bone sarcomas (STBS) may benefit from intensive local treatment, such as stereotactic radiotherapy (SRT).This study aimed to summarize the utilization and outcomes of SRT in STBS and to identify predictive factors for progression and survival.Materials and methods: